Act Capital Management, LLC Nektar Therapeutics Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$3.17 - $6.17 $19,020 - $37,020
-6,000 Closed
0 $0
Q1 2022

May 11, 2022
SELL
$4.16 - $13.72 $166,400 - $548,800
-40,000 Reduced 86.96%
6,000 $32,000
Q4 2021

Feb 03, 2022
SELL
$10.83 - $18.41 $1.25 Million - $2.13 Million
-115,500 Reduced 71.52%
46,000 $621,000
Q2 2021

Aug 16, 2021
BUY
$16.52 - $20.4 $2.67 Million - $3.29 Million
161,500 New
161,500 $2.77 Million

Others Institutions Holding NKTR

# of Institutions
140
Shares Held
135M
Call Options Held
32.8K
Put Options Held
55.5K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $244M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email